RespireRx Pharmaceuticals Inc (fka RSPI)

[Dj56]

With Lilly , a giant pharma, having one helpful compound towards epilepsy,

And rspi having a new sales guy previously having worked for Lilly,

Seems with the reported efficacy of rspi's epilepsy compound,

Lilly would be more interested buying rspi's compound into their organization, rather than go to a competitor, and while rspi is more needful of cash, Lilly might get it as cheap as ever if they move swiftly?